Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Blackstone
Biotech
Blackstone bets $750M on Moderna's flu program
Blackstone is making a $750 million bet on Moderna’s flu program as part of the investment platform’s push to “support innovative mRNA technology.”
James Waldron
Mar 27, 2024 8:54am
Blackstone's $250M bet beats Xarelto in phase 2 bleeding trial
Sep 18, 2023 6:00am
Blackstone, Sutro ink royalty pact worth up to $390M biobucks
Jun 26, 2023 1:47pm
Blackstone bets on Autolus' CD19 CAR-T in $250M deal
Nov 8, 2021 7:15am
Medable's virtual trials push gets $304M bet to edge out others
Oct 26, 2021 12:14pm
BioMed bets $1.2B to ease U.K. life science capacity crunch
Sep 21, 2021 7:45am